Variation in the eNOS gene modifies the association between total energy expenditure and glucose intolerance

Diabetes

Volumn 54, Issue 9, 2005, Pages 2795-2801

  Franks, Paul W ^a,b   Luan, Jian'an ^a   Barroso, Inês ^c   Brage, Søren ^a   Sanchez, Jose Luis Gonzalez ^d   Ekelund, Ulf ^a   Ríos, Manuel Serrano ^d   Schafer, Alan J ^e   O'Rahilly, Stephen ^f   Wareham, Nicholas J ^a,g  

^a MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e Botanic House   (United Kingdom)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ADULT; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; GENE INDUCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; SPAIN; UNITED KINGDOM;

AGED; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FEMALE; GLUCOSE INTOLERANCE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 24144503309     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.9.2795     Document Type: Article

References (51)

1. Pedersen O: Genetics of insulin resistance. Exp Clin Endocrinol Diabetes 107:113-118, 1999
2. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622, 2002
3. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:771-776, 1992
4. Culotta E, Koshland DE Jr: NO news is good news. Science 258:1862-1865, 1992
5. Reid MB: Invited Review: redox modulation of skeletal muscle contraction: what we know and what we don't. J Appl Physiol 90:724-731, 2001
6. Balon TW, Nadler JL: Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 82:359-363, 1997
7. Roberts CK, Barnard RJ, Jasman A, Balon TW: Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J Physiol Endocrinol Metab 277:E390-E394, 1999
8. Balon TW, Nadler JL: Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 77:2519-2521, 1994
9. Yang AL, Tsai SJ, Jiang MJ, Jen CJ, Chen H: Chronic exercise increases both inducible and endothelial nitric oxide synthase gene expression in endothelial cells of rat aorta. J Biomed Sci 9:149-155, 2002
10. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ: Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 50:241-247, 2001
11. Roy D, Perreault M, Marette A: Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol Endocrinol Metab 274:E692-E699, 1998
12. Bradley S, Kingwell B, McConell G: Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes 48:1815-1821, 1999
13. [erratum Diabetes 48:2480, 1999]
14. Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF, Mohr FW, Schuler G: Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107:3152-3158, 2003
15. Kojda G, Cheng YC, Burchfield J, Harrison DG: Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation 103:2839-2844, 2001
16. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, Scherrer U: Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104:342-345, 2001
17. Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, Wareham NJ: Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. Hum Mol Genet 11:1581-1583, 2002
18. Halsall DJ, McFarlane I, Luan J, Cox TM, Wareham NJ: Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case-control study. Hum Mol Genet 12:1361-1365, 2003
19. Spurr GB, Prentice AM, Murgatroyd PR, Goldberg GR, Reina JC, Christman NT: Energy expenditure from minute-by-minute heart-rate recording: comparison with indirect calorimetry. Am J Clin Nutr 48:552-559, 1988
20. Livingstone MB, Coward WA, Prentice AM, Davies PS, Strain JJ, McKenna PG, Mahoney CA, White JA, Stewart CM, Kerr MJ: Daily energy expenditure in free-living children: comparison of heart-rate monitoring with the doubly labeled water (2H2(18)O) method. Am J Clin Nutr 56:343-352, 1992
21. Ceesay SM, Prentice AM, Day KC, Murgatroyd PR, Goldberg GR, Scott W: The use of heart rate monitoring in the estimation of energy expenditure: a validation study using indirect whole-body calorimetry. Br J Nutr 61:175-186, 1989
22. Williams DRR, Wareham NJ, Brown DC, Byrne CD, Clark PMS, Cox BD, Cox LJ, Day NE, Hales CN, Palmer CR, Shackleton JR, Wang TWM: Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 12:30-35, 1994
23. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN: Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22:262-270, 1999
24. González-Sánchez JL, Zabena CA, Martínez-Larrad MT, Fernández-Pérez C, Pérez-Barba M, Laakso M, Serrano-Ríos M: An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 13:807-812, 2005
25. Chen C, Dun SL, Dun NJ, Chang JK: Prolactin-releasing peptide-immunoreactivity in A1 and A2 noradrenergic neurons of the rat medulla. Brain Res 822:276-279, 1999
26. Savage DB, Agostini M, Barroso I, Gurnell M, Luan J, Meirhaeghe A, Harding AH, Ihrke G, Rajanayagam O, Soos MA, George S, Berger D, Thomas EL, Bell JD, Meeran K, Ross RJ, Vidal-Puig A, Wareham NJ, O'Rahilly S, Chatterjee VK, Schafer AJ: Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet 31:379-384, 2002
27. Thorpe KL, Schafer AJ, Genin E, Trowsdale J, Beck S: Detection of polymorphism in the RING3 gene by high-throughput fluorescent SSCP analysis. Immunogenetics 49:256-265, 1999
28. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
29. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
30. An P, Freedman BI, Hanis CL, Chen YD, Weder AB, Schork NJ, Boerwinkle E, Province MA, Hsiung CA, Wu X, Quertermous T, Rao DC: Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis. Diabetes 54:909-914, 2005
31. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, Valsecchi G, Lucotti P, Pozza G, Bernardinelli L, Casari G, Piatti P: Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52:1270-1275, 2003
32. Benjafield AV, Morris BJ: Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens 13:994-998, 2000
33. Neugebauer S, Baba T, Watanabe T: Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49:500-503, 2000
34. Taniwaki H, Ishimura E, Matsumoto N, Emoto M, Inaba M, Nishizawa Y: Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care 24:1653-1660, 2001
35. Taverna MJ, Sola A, Guyot Argenton C, Pacher N, Bruzzo F, Chevalier A, Slama G, Reach G, Selam JL: eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabet Med 19:240-245, 2002
36. Casas JP, Bautista LE, Humphries SE, Hingorani AD: Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109:1359-1365, 2004
37. McDonald DM, Alp NJ, Channon KM: Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics 14:831-839, 2004
38. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, Smits P: The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 20:2023-2027, 2002
39. Poehlman ET, Dvorak RV, DeNino WF, Brochu M, Ades PA: Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial. J Clin Endocrinol Metab 85:2463-2468, 2000
40. Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ: Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286:1218-1227, 2001
41. Holloszy JO, Schultz J, Kusnierkiewicz J, Hagberg JM, Ehsani AA: Effects of exercise on glucose tolerance and insulin resistance: brief review and some preliminary results. Acta Med Scand Suppl 711:55-65, 1986
42. Roy D, Perreault M, Marette A: Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol Endocrinol Metab 274:E692-E699, 1998
43. Etgen GJ Jr, Fryburg DA, Gibbs EM: Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes 46:1915-1919, 1997
44. Tanaka T, Nakatani K, Morioka K, Urakawa H, Maruyama N, Kitagawa N, Katsuki A, Araki-Sasaki R, Hori Y, Gabazza EC, Yano Y, Wada H, Nobori T, Sumida Y, Adachi Y: Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes. Eur J Endocrinol 149:61-67, 2003
45. Balon TW, Yerneni KK: Redox regulation of skeletal muscle glucose transport. Med Sci Sports Exerc 33:382-385, 2001
46. Rankinen T, Rice T, Perusse L, Chagnon YC, Gagnon J, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C: NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study. Hypertension 36:885-889, 2000
47. Kimura T, Yokoyama T, Matsumura Y, Yoshiike N, Date C, Muramatsu M, Tanaka H: NOS3 genotype-dependent correlation between blood pressure and physical activity. Hypertension 41:355-360, 2003
48. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA: Haplotype tagging for the identification of common disease genes. Nat Genet 29:233-237, 2001
49. Dempster AP, Laird NM, Rubin DB: Maximum likelihood from incomplete data via the EM algorithm. J Royal Statistical Soc 39 (Ser. B):1-38, 1977
50. Adkins RM: Comparison of the accuracy of methods of computational haplotype inference using a large empirical dataset. BMC Genet 5:22, 2004
51. Walley AJ, Aucan C, Kwiatkowski D, Hill AV: Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Eur J Hum Genet 12:132-138, 2004